BI

BiomeBank

1 known investors

biomebank.com ↗

BiomeBank develops living microbial therapeutics derived from human gut microbiome collections, targeting conditions such as ulcerative colitis with a pipeline spanning immunity, metabolism, neurology and oncology. The company builds co-cultured microbial ecosystem therapies using its CONSORTIOME platform.

Investors · 1

SO

South Australian Venture Capital FundAdelaide · $400K – $2.5M